HUMACYTE INC's ticker is and the CUSIP is 44486Q103. A total of 72 filers reported holding HUMACYTE INC in Q3 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $1 | 0.0% | 400 | 0.0% | 0.00% | 0.0% |
| Q3 2023 | $1 | 0.0% | 400 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $1 | 0.0% | 400 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $1 | – | 400 | 0.0% | 0.00% | – |
| Q4 2022 | $0 | -100.0% | 400 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $1,000 | 0.0% | 400 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $1,000 | -50.0% | 400 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $2,000 | -71.4% | 400 | -60.0% | 0.00% | -50.0% |
| Q4 2021 | $7,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Endowment Wealth Management, Inc. | 100,518 | $482,486 | 0.35% |
| Monashee Investment Management LLC | 280,000 | $1,344,000 | 0.17% |
| United Asset Strategies, Inc. | 218,308 | $1,047,878 | 0.10% |
| HAMILTON LANE ADVISORS LLC | 21,893 | $105,086 | 0.08% |
| GSA CAPITAL PARTNERS LLP | 224,179 | $1,076 | 0.08% |
| David J Yvars Group | 22,750 | $109,200 | 0.07% |
| ARS Investment Partners, LLC | 116,419 | $558,811 | 0.05% |
| EntryPoint Capital, LLC | 5,180 | $24,864 | 0.04% |
| Virtu Financial LLC | 103,163 | $495 | 0.04% |
| Anson Funds Management LP | 50,000 | $240,000 | 0.03% |